Advertisements

Palatin Technologies Inc. (PTN) Stock Quote

Detailed Quote for Palatin Technologies Inc. (PTN)
$ 0.89   -0.0247 (-2.70%) Volume: 380.15k 9:58 AM EDT Jun 19, 2018
Today 5d 1m 3m 1y more
Last Price
0.89
Change $
0.0247
Change %
2.70%
Tick
N/A
Bid
0.89
Bid Size
3,500
Ask
0.8901
Ask Size
500
Open
0.90
High
0.9119
Low
0.885
Prev Close
0.9147
Last Trade
9:58
Volume
380.15k
52 Wk Hi
1.59000003
52 Wk Low
0.344000011
Market Cap
176.82m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
198,677,039
EPS (TTM)
0.14
PE Ratio
6.70
Exchange
NYSE American
News and Media for Palatin Technologies Inc. (PTN)
Sector News | Topic News
News for Palatin Technologies Inc. (PTN)
Wed, Jun 06, 2018
7:30 AM Stock Performance Review on TherapeuticsMD and Three Other Healthcare Stocks - ACCESSWIRE IA
1:36 AM Your Daily Pharma Scoop: Iovance Zooms Ahead, Palatin Surges And Deciphera Moves Up - SeekingAlpha
Mon, Jun 04, 2018
9:17 AM Premarket Gainers as of 9:05 am (06/04/2018) - SeekingAlpha
7:47 AM FDA accepts Palatin Technologies' NDA review for bremelanotide - SeekingAlpha
7:10 AM Palatin Technologies Announces FDA Acceptance for Review of Bremelanotide NDA - PR Newswire
Tue, May 15, 2018
4:46 PM Palatin Technologies' (PTN) CEO Carl Spana on Q3 2018 Results - Earnings Call Transcript - SeekingAlpha
9:30 AM Palatin Tech revenues down 17%; net loss improves in Q1 - SeekingAlpha
7:32 AM Palatin Tech beats by $0.04 - SeekingAlpha
7:30 AM Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on May 15, 2018 - PR Newswire
Thu, May 10, 2018
4:30 PM Palatin Technologies, Inc. to Report Third Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on May 15, 2018 - PR Newswire
8:10 AM Factors of Influence in 2018, Key Indicators and Opportunity within American Homes 4 Rent, Discovery Communications, Vertex Pharmaceuticals, The New York Times, Palatin Technologies, and E*TRADE Financial - New Research Emphasizes Economic Growth - GlobeNewswire
Wed, May 09, 2018
9:20 AM Premarket Gainers as of 9:05 am (05/09/2018) - SeekingAlpha
7:30 AM Palatin Technologies Presents Positive Preclinical MC1 Receptor Agonist Data at TIDES: Oligonucleotide and Peptide Therapeutics 2018 Meeting in Boston, Massachusetts - PR Newswire
Mon, Apr 23, 2018
9:19 AM Premarket Losers as of 9:05 am (4/23/2018) - SeekingAlpha
Thu, Apr 19, 2018
9:24 AM Premarket Losers as of 9:05 am (04/19/2018) - SeekingAlpha
Tue, Apr 10, 2018
9:25 AM Premarket Gainers as of 9:05 am (04/10/2018) - SeekingAlpha
Tue, Apr 03, 2018
7:30 AM Palatin Technologies Presents Preclinical Oral Formulation Data on PL-8177, An Investigational Melanocortin Receptor 1 Agonist for Inflammatory Bowel Diseases - PR Newswire
Mon, Mar 26, 2018
9:17 AM Premarket Gainers as of 9:05 am (03/26/2018) - SeekingAlpha
8:00 AM Palatin Technologies Announces Submission of Bremelanotide NDA to FDA for Treatment of Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women - PR Newswire
Thu, Mar 08, 2018
7:50 AM Detailed Research: Economic Perspectives on HMS, Colfax, Fossil Group, Palatin Technologies, FIS, and Commercial Metals - What Drives Growth in Today's Competitive Landscape - GlobeNewswire
More News for PTN >>

Tags for Palatin Technologies Inc.

Research stocks or mutual funds related to Palatin Technologies Inc. by keywords or tags. Find companies that have a similar focus to PTN. The keywords below have been associated to PTN by either user submission or electronic means.

pharmaceutical articles biotech research pharmaceutical industry strategy pharmaceutical publication pharmaceutical market pharmaceuticals companies generic pharmaceutical jobs in pharmaceutical mgi pharma biotechnology market pharmaceutical manufacturing company pharma manufacturing pharma license novartis pharmaceuticals cv therapeutics pharmaceutical class active pharmaceutical ingredient pharmaceutical cro active pharmaceutical ingredients pharmaceutical sales pharma pharmaceutical distributors pharmaceutical development pharmaceutical reports pharmaceutical magazine biotech Drugs pharmaceutical auctions pharmaceutical manufacturing software pharmaceutical conference pharmaceutical manufacturing pharmaceutical formulation pharmaceutical article pfizer pharmaceuticals barrier therapeutics contract pharmaceutical pharmaceutical consulting pharmaceutical industry veterinary pharmaceutical patent research pharmaceutical advances pharmaceutical distributor therapeutics products pharmaceutical out licensing pharmaceutical co promotion merck pharmaceuticals pharmaceutical business development Healthcare pharmaceutical preparation pharmaceutical sector